AI assistant
Sending…
Biofrontera Inc. — Director's Dealing 2021
Dec 14, 2021
35198_dirs_2021-12-13_4166b55a-723a-4aa0-b23f-84e1209fb213.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Biofrontera Inc. (BFRI)
CIK: 0001858685
Period of Report: 2021-12-09
Reporting Person: Gates Erica F. (Controller)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-09 | Employee stock option (right to buy) | $4.41 | A | 20408 | Acquired | 2031-12-09 | Common Stock (20408) | Direct |
Footnotes
F1: The option vests in three equal annual installments beginning on December 9, 2022.